Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1

Molecular Brain Research

Volumn 132, Issue 2, 2004, Pages 241-259

  Vercauteren, Freya G G ^a,b   Clerens, Stefan ^b   Roy, Line ^c   Hamel, Nathalie ^c   Arckens, Lut ^b   Vandesande, Frans ^b   Alhonen, Leena ^d   Janne, Juhani ^d   Szyf, Moshe ^a   Cuello, A Claudio ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Reseau Proteomique Montreal M   (Canada)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Brain mapping; Hippocampus; Learning; Memory; Nerve degeneration; Presenilin 1; Two dimensional gel electrophoresis

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PROTEOME;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL TISSUE; BRAIN REGION; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; EXTRACELLULAR SPACE; GENE MUTATION; GENETIC LINKAGE; HIPPOCAMPUS; LEARNING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT TERM MEMORY; SPATIAL MEMORY; TRANSGENE; TRANSGENIC ANIMAL; UNINDEXED SEQUENCE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN CHEMISTRY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HIPPOCAMPUS; LEARNING; MALE; MEMBRANE PROTEINS; MEMORY; MUTAGENESIS, SITE-DIRECTED; PRESENILIN-1; PROTEOMICS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 9744239546     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.10.012     Document Type: Conference Paper

References (100)

1. K. Abe, and H. Kimura The possible role of hydrogen sulfide as an endogenous neuromodulator J. Neurosci. 16 1996 1066 1071
2. Z. Asztalos, J. von Wegerer, G. Wustmann, V. Dombradi, J. Gausz, H.C. Spatz, and P. Friedrich Protein phosphatase 1-deficient mutant Drosophila is affected in habituation and associative learning J. Neurosci. 13 1993 924 930
3. D.S. Auld, S. Kar, and R. Quirion Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends Neurosci. 21 1998 43 49
4. J. Avila, F. Lim, F. Moreno, C. Belmonte, and A.C. Cuello Tau function and dysfunction in neurons: its role in neurodegenerative disorders Mol. Neurobiol. 25 2002 213 231
5. M.J. Ball Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study Acta Neuropathol. (Berl.) 37 1977 111 118
6. K. Beyreuther, and C.L. Masters Serpents on the road to dementia and death Nat. Med. 3 1997 723 725
7. M.L. Billingsley, and R.L. Kincaid Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration Biochem. J. 323 Pt. 3 1997 577 591
8. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein using the principal of dye binding Ann. Biochem. 72 1976 248 254
9. L. Brattstrom, A. Lindgren, B. Israelsson, A. Andersson, and B. Hultberg Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects J. Intern. Med. 236 1994 633 641
10. D.A. Butterfield, D. Boyd-Kimball, and A. Castegna Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration J. Neurochem. 86 2003 1313 1327
11. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic. Biol. Med. 33 2002 562 571
12. P.E. Castillo, S. Schoch, F. Schmitz, T.C. Sudhof, and R.C. Malenka RIM1alpha is required for presynaptic long-term potentiation Nature 415 2002 327 330
13. S. Cavallaro, N. Meiri, C.L. Yi, S. Musco, W. Ma, J. Goldberg, and D.L. Alkon Late memory-related genes in the hippocampus revealed by RNA fingerprinting Proc. Natl. Acad. Sci. U. S. A. 94 1997 9669 9673
14. G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, S.J. Martin, A. Justice, L. McConlogue, D. Games, S.B. Freedman, and R.G. Morris A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease Nature 408 2000 975 979
15. S. David, M. Shoemaker, and B.E. Haley Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning Brain Res. Mol. Brain Res. 54 1998 276 287
16. W.M. DeBello, V. O'Connor, T. Dresbach, S.W. Whiteheart, S.S. Wang, F.E. Schweizer, H. Betz, J.E. Rothman, and G.J. Augustine SNAP-mediated protein-protein interactions essential for neurotransmitter release Nature 373 1995 626 630
17. G.V. De Ferrari, and N.C. Inestrosa Wnt signaling function in Alzheimer's disease Brain Res. Brain Res. Rev. 33 2000 1 12
18. I. Dewachter, D. Moechars, J. van Dorpe, I. Tesseur, H.C. Van den, K. Spittaels, and F. Van Leuven Modelling Alzheimer's disease in multiple transgenic mice Biochem. Soc. Symp. 2001 203 210
19. E. Dowd, S.B. Dunnet, and A.C. Cuello Poor spatial learning in transgenic rats that accumulate A intracellularly in the hippocampus and cortex but do not develop extracellular plaques Soc. Neurosci. Abstr. 881 2002 5
20. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M.N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy, and S. Younkin Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1 Nature 383 1996 710 713
21. V. Echeverria, and A.C. Cuello Intracellular A-beta amyloid, a sign for worse things to come? Mol. Neurobiol. 26 2002 299 316
22. V. Echeverria, A. Ducatenzeiler, L. Alhonen, J. Janne, S.M. Grant, F. Wandosell, A. Muro, F. Baralle, H. Li, K. Duff, M. Szyf, and A.C. Cuello Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex J. Alzheimer's Dis. 6 2004 209 219
23. V. Echeverria, A. Ducatenzeiler, E. Dowd, J. Janne, S.M. Grant, M. Szyf, F. Wandosell, J. Avila, H. Grimm, S.B. Dunnet, T. Hartmann, L. Alhonen, and A.C. Cuello Altered MAPK signalling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons Neuroscience 2004 (in press)
24. K. Eto, and H. Kimura The production of hydrogen sulfide is regulated by testosterone and S-adenosyl-l-methionine in mouse brain J. Neurochem. 83 2002 80 86
25. Y. Fukata, T.J. Itoh, T. Kimura, C. Menager, T. Nishimura, T. Shiromizu, H. Watanabe, N. Inagaki, A. Iwamatsu, H. Hotani, and K. Kaibuchi CRMP-2 binds to tubulin heterodimers to promote microtubule assembly Nat. Cell Biol. 4 2002 583 591
26. D. Genoux, U. Haditsch, M. Knobloch, A. Michalon, D. Storm, and I.M. Mansuy Protein phosphatase 1 is a molecular constraint on learning and memory Nature 418 2002 970 975
27. F. Gharahdaghi, C.R. Weinberg, D.A. Meagher, B.S. Imai, and S.M. Mische Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity Electrophoresis 20 1999 601 605
28. M.E. Gibbs, B.S. O'Dowd, L. Hertz, S.R. Robinson, G.L. Sedman, and K.T. Ng Inhibition of glutamine synthetase activity prevents memory consolidation Brain Res. Cogn. Brain Res. 4 1996 57 64
29. J. Glowinski, and L.L. Iversen Regional studies of catecholamines in the rat brain: I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain J. Neurochem. 13 1966 655 669
30. Y. Goda SNAREs and regulated vesicle exocytosis Proc. Natl. Acad. Sci. U. S. A. 94 1997 769 772
31. G.K. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J.P. Greenfield, V. Haroutunian, J.D. Buxbaum, H. Xu, P. Greengard, and N.R. Relkin Intraneuronal Ab42 accumulation in human brain Am. J. Pathol. 156 2000 15 20
32. E. Gozal, D. Gozal, W.M. Pierce, V. Thongboonkerd, J.A. Scherzer, L.R. Sachleben Jr., K.R. Brittian, S.Z. Guo, J. Cai, and J.B. Klein Proteomic analysis of CA1 and CA3 regions of rat hippocampus and differential susceptibility to intermittent hypoxia J. Neurochem. 83 2002 331 345
33. C. Haass, and B. De Strooper The presenilins in Alzheimer's disease-proteolysis holds the key Science 286 1999 916 919
34. A.S. Harris, and J.S. Morrow Calmodulin and calcium-dependent protease I coordinately regulate the interaction of fodrin with actin Proc. Natl. Acad. Sci. U. S. A. 87 1990 3009 3013
35. R. Hashimoto, Y. Nakamura, S. Komai, Y. Kashiwagi, N. Matsumoto, S. Shiosaka, and M. Takeda Phosphorylation of neurofilament-L during LTD NeuroReport 11 2000 2739 2742
36. R. Hashimoto, Y. Nakamura, S. Komai, Y. Kashiwagi, K. Tamura, T. Goto, S. Aimoto, K. Kaibuchi, S. Shiosaka, and M. Takeda Site-specific phosphorylation of neurofilament-L is mediated by calcium/calmodulin-dependent protein kinase II in the apical dendrites during long-term potentiation J. Neurochem. 75 2000 373 382
37. E. Hellstrom-Lindahl Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors Eur. J. Pharmacol. 393 2000 255 263
38. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat. Med. 4 1998 97 100
39. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
40. C.C. Huang, Y.C. Liang, and K.S. Hsu Characterization of the mechanism underlying the reversal of long term potentiation by low frequency stimulation at hippocampal CA1 synapses J. Biol. Chem. 276 2001 48108 48117
41. B.T. Hyman, G.W. Van Horsen, A.R. Damasio, and C.L. Barnes Alzheimer's disease: cell-specific pathology isolates the hippocampal formation Science 225 1984 1168 1170
42. B.T. Hyman, G.W. van Hoesen, L.J. Kromer, and A.R. Damasio Perforant pathway changes and the memory impairment of Alzheimer's disease Ann. Neurol. 20 1986 472 481
43. K. Iqbal, A.C. Alonso, C.X. Gong, S. Khatoon, J.J. Pei, J.Z. Wang, and I. Grundke-Iqbal Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles J. Neural Transm., Suppl. 53 1998 169 180
44. M.C. Irizarry, M. McNamara, K. Fedorchak, K. Hsiao, and B.T. Hyman APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1 J. Neuropathol. Exp. Neurol. 56 1997 965 973
45. M.C. Irizarry, F. Soriano, M. McNamara, K.J. Page, D. Schenk, D. Games, and B.T. Hyman Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse J. Neurosci. 17 1997 7053 7059
46. C.R. Jost, C.E. Van der Zee, H.J. In 't Zandt, F. Oerlemans, M. Verheij, F. Streijger, J. Fransen, A. Heerschap, A.R. Cools, and B. Wieringa Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility Eur. J. Neurosci. 15 2002 1692 1706
47. K. Kanamori, and B.D. Ross Steady-state in vivo glutamate dehydrogenase activity in rat brain measured by 15N NMR J. Biol. Chem. 270 1995 24805 24809
48. K. Kanninen, G. Goldsteins, S. Auriola, I. Alafuzoff, and J. Koistinaho Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach Neurosci. Lett. 367 2004 235 240
49. S. Kar, A.M. Issa, D. Seto, D.S. Auld, B. Collier, and R. Quirion Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices J. Neurochem. 70 1998 2179 2187
50. S.Y. Kawaguchi, and T. Hirano Signaling cascade regulating long-term potentiation of GABA(A) receptor responsiveness in cerebellar Purkinje neurons J. Neurosci. 22 2002 3969 3976
51. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
52. C.H. Kim, and J.E. Lisman A role of actin filament in synaptic transmission and long-term potentiation J. Neurosci. 19 1999 4314 4324
53. H. Kimura Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor Biochem. Biophys. Res. Commun. 267 2000 129 133
54. S. Kishida, H. Shirataki, T. Sasaki, M. Kato, K. Kaibuchi, and Y. Takai Rab3A GTPase-activating protein-inhibiting activity of Rabphilin-3A, a putative Rab3A target protein J. Biol. Chem. 268 1993 22259 22261
55. T. Krucker, G.R. Siggins, and S. Halpain Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus Proc. Natl. Acad. Sci. U. S. A. 97 2000 6856 6861
56. I.I. Kruman, C. Culmsee, S.L. Chan, Y. Kruman, Z. Guo, L. Penix, and M.P. Mattson Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity J. Neurosci. 20 2000 6920 6926
57. I.I. Kruman, T.S. Kumaravel, A. Lohani, R.G. Cutler, Y. Kruman, N. Haughey, W.A. Pedersen, M.K. Evans, and M.P. Mattson Folate deficiency and homocysteine enhance amyloid toxicity by impairing DNA repair Soc. Neurosci. Abstr. 31 2001 962.9
58. I.I. Kruman, T.S. Kumaravel, A. Lohani, W.A. Pedersen, R.G. Cutler, Y. Kruman, N. Haughey, J. Lee, M. Evans, and M.P. Mattson Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease J. Neurosci. 22 2002 1752 1762
59. P. Krzywkowski, O. Ghribi, J. Gagne, C. Chabot, S. Kar, J. Rochford, G. Massicotte, and J. Poirier Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice Neuroscience 92 1999 1273 1286
60. C.A. Lemere, J.K. Blusztajn, H. Yamaguchi, T. Wisniewski, T.C. Saido, and D.J. Selkoe Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation Neurobiol. Dis. 3 1996 16 32
61. J. Lisman A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory Proc. Natl. Acad. Sci. U. S. A. 86 1989 9574 9578
62. P.M. Lledo, X. Zhang, T.C. Sudhof, R.C. Malenka, and R.A. Nicoll Postsynaptic membrane fusion and long-term potentiation Science 279 1998 399 403
63. G. Lubec, M. Nonaka, K. Krapfenbauer, M. Gratzer, N. Cairns, and M. Fountoulakis Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level J. Neural Transm., Suppl. 57 1999 161 177
64. M. Maki, N. Matsukawa, H. Yuasa, Y. Otsuka, T. Yamamoto, H. Akatsu, T. Okamoto, R. Ueda, and K. Ojika Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease J. Neuropathol. Exp. Neurol. 61 2002 176 185
65. M.P. Mattson, I.I. Kruman, and W. Duan Folic acid and homocysteine in age-related disease Ageing Res. Rev. 1 2002 95 111
66. A. Matus, H. Brinkhaus, and U. Wagner Actin dynamics in dendritic spines: a form of regulated plasticity at excitatory synapses Hippocampus 10 2000 555 560
67. T.J. McHugh, K.I. Blum, J.Z. Tsien, S. Tonegawa, and M.A. Wilson Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice Cell 87 1996 1339 1349
68. S. Mitake, K. Ojika, E. Katada, Y. Otsuka, N. Matsukawa, and O. Fujimori Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies Neuropathol. Appl. Neurobiol. 21 1995 35 40
69. S. Mitake, K. Ojika, and A. Hirano Hirano bodies and Alzheimer's disease, Kaohsiung J. Med. Sci. 13 1997 10 18
70. M. Miyazaki, K. Kaibuchi, H. Shirataki, H. Kohno, T. Ueyama, J. Nishikawa, and Y. Takai Rabphilin-3A binds to a M(r) 115,000 polypeptide in a phosphatidylserine- and Ca(2+)-dependent manner Brain Res. Mol. Brain Res. 28 1995 29 36
71. C. Mori, E.T. Spooner, K.E. Wisniewsk, T.M. Wisniewski, H. Yamaguch, T.C. Saido, D.R. Tolan, D.J. Selkoe, and C.A. Lemere Intraneuronal Abeta42 accumulation in Down syndrome brain Amyloid 9 2002 88 102
72. W. Morishita, J.H. Connor, H. Xia, E.M. Quinlan, S. Shenolikar, and R.C. Malenka Regulation of synaptic strength by protein phosphatase 1 Neuron 32 2001 1133 1148
73. R.M. Mulkey, S. Endo, S. Shenolikar, and R.C. Malenka Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression Nature 369 1994 486 488
74. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, and J.D. Buxbaum Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA 283 2000 1571 1577
75. A.S. Nayak, C.I. Moore, and M.D. Browning Ca2+/calmodulin-dependent protein kinase II phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation Proc. Natl. Acad. Sci. U. S. A. 93 1996 15451 15456
76. K.T. Ng, B.S. O'Dowd, N.S. Rickard, S.R. Robinson, M.E. Gibbs, C. Rainey, W.Q. Zhao, G.L. Sedman, and L. Hertz Complex roles of glutamate in the Gibbs-Ng model of one-trial aversive learning in the new-born chick Neurosci. Biobehav. Rev. 21 1997 45 54
77. D.N. Perkins, D.J. Pappin, D.M. Creasy, and J.S. Cottrell Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 20 1999 3551 3567
78. I.P. Pogribny, A.G. Basnakian, B.J. Miller, N.G. Lopatina, L.A. Poirier, and S.J. James Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats Cancer Res. 55 1995 1894 1901
79. J. Poirier Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease J. Psychiatry Neurosci. 24 1999 147 153
80. J. Poirier, M.C. Delisle, R. Quirion, I. Aubert, M. Farlow, D. Lahiri, S. Hui, P. Bertrand, J. Nalbantoglu, B.M. Gilfix, and S. Gauthier Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 92 1995 12260 12264
81. D.L. Price, R.E. Tanzi, D.R. Borchelt, and S.S. Sisodia Alzheimer's disease: genetic studies and transgenic models Annu. Rev. Genet. 32 1998 461 493
82. C.C. Quinn, G.E. Gray, and S. Hockfield A family of proteins implicated in axon guidance and outgrowth J. Neurobiol. 41 1999 158 164
83. S.R. Robinson Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease J. Neurosci. Res. 66 2001 972 980
84. K. Sakimura, T. Kutsuwada, I. Ito, T. Manabe, C. Takayama, E. Kushiya, T. Yagi, S. Aizawa, Y. Inoue, H. Sugiyama, and M. Mishina Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit Nature 373 1995 151 155
85. G. Schiavo, M.J. Gmachl, G. Stenbeck, T.H. Sollner, and J.E. Rothman A possible docking and fusion particle for synaptic transmission Nature 378 1995 733 736
86. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L. Faull, and G.J. Cooper Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process Proteomics 1 2001 1519 1528
87. N. Schupf, B. Patel, W. Silverman, W.B. Zigman, N. Zhong, B. Tycko, P.D. Mehta, and R. Mayeux Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome Neurosci. Lett. 301 2001 199 203
88. J. Selhub, L.C. Bagley, J. Miller, and I.H. Rosenberg B vitamins, homocysteine, and neurocognitive function in the elderly Am. J. Clin. Nutr. 71 2000 614S 620S
89. D.J. Selkoe Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease J. Clin. Invest. 110 2002 1375 1381
90. H. Shirataki, K. Kaibuchi, T. Yamaguchi, K. Wada, H. Horiuchi, and Y. Takai A possible target protein for smg-25A/rab3A small GTP-binding protein J. Biol. Chem. 267 1992 10946 10949
91. H. Shirataki, K. Kaibuchi, T. Sakoda, S. Kishida, T. Yamaguchi, K. Wada, M. Miyazaki, and Y. Takai Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin Mol. Cell. Biol. 13 1993 2061 2068
92. T. Sollner, S.W. Whiteheart, M. Brunner, H. Erdjument-Bromage, S. Geromanos, P. Tempst, and J.E. Rothman SNAP receptors implicated in vesicle targeting and fusion Nature 362 1993 318 324
93. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Burki, P. Frey, P.A. Paganetti, C. Waridel, M.E. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, and B. Sommer Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc. Natl. Acad. Sci. U. S. A. 94 1997 13287 13292
94. R.E. Tanzi, D.M. Kovacs, T.W. Kim, R.D. Moir, S.Y. Guenette, and W. Wasco The gene defects responsible for familial Alzheimer's disease Neurobiol. Dis. 3 1996 159 168
95. K. Tilleman, I. Stevens, K. Spittaels, C.V. Haute, S. Clerens, B.G. Van Den, H. Geerts, F. Van Leuven, F. Vandesande, and L. Moens Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view Proteomics 2 2002 94 104
96. I. Veinbergs, M.W. Jung, S.J. Young, E. Van Uden, P.M. Groves, and E. Masliah Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice Neurosci. Lett. 249 1998 71 74
97. E. Wainfan, and L.A. Poirier Methyl groups in carcinogenesis: effects on DNA methylation and gene expression Cancer Res. 52 1992 2071s 2077s
98. M.S. Wolfe, W. Xia, B.L. Ostaszewski, T.S. Diehl, W.T. Kimberly, and D.J. Selkoe Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity Nature 398 1999 513 517
99. N.H. Woo, and P.V. Nguyen "Silent" metaplasticity of the late phase of long-term potentiation requires protein phosphatases Learn. Mem. 9 2002 202 213
100. A.C. Yu, T.E. Fisher, E. Hertz, J.T. Tildon, A. Schousboe, and L. Hertz Metabolic fate of [14C]-glutamine in mouse cerebral neurons in primary cultures J. Neurosci. Res. 11 1984 351 357